spacer
home > pmps > winter 2001 > an introduction to transdermal drug delivery systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

An Introduction to Transdermal Drug Delivery Systems

In the first part of this article in the Autumn 2001 issue of PMPS, we analysed the varieties, the structure and the basic components of patches. This 'promenade' was important in order to better understand how these drug delivery systems are composed. In this second part we will follow the processes involved in the production of the two major classes, matrix and liquid reservoir patches. We will then finish with a detailed description of the whole production chain for the most popular class at present - the matrix systems.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Spyridon A. Fotinos, Executive Vice President - Corporate Research & Innovation, at Lavipharm Group of Companies
Spyridon Fotinos studied pharmaceutics at the University of Athens, before going on to study chemistry at the University of Thessaloniki. He joined Lavipharm in 1979, and in 1987, established the Research and Development Department, of which he has since become a Director.
Spyridon's current position is Executive Vice President - Corporate Research and Innovation. Prior to his time at Lavipharm, he served for four years as Director of Planning and Studies at Minerva Pharmaceuticals. Spyridon is a patent holder in the areas of pharmaceutical and cosmetic delivery technology, antioxidant and enzymic systems. He is also a member of several Greek and international scientific organisations.

spacer
Spyridon A. Fotinos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Shipping with Active Packaging Containers: Three Pre-flight Decisions that Impact the Success of High-value Global Shipments

World Courier

It is the dead of winter in the northern hemisphere and the height of summer in the southern, with external temperature fluctuations exceeding 50 degrees. Flight delays have added precious days to the transport of your multi-million dollar shipment of blockbuster drug from South East Asia destined for Russia. In France, the roads are closed for days due to a monster snowstorm, with your irreplaceable shipment of investigational drugs stopped somewhere en route between Paris and the clinical trial site. Will all be lost, or can informed choices made before the shipment departs ensure product safety despite unforeseen circumstances?
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement